ESC 365 - Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention and using direct oral anticoagulants

ESC2025 Premium Access

Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention and using direct oral anticoagulants

Session: Pharmacotherapy in acute coronary syndromes (1)

Topic: Pharmacotherapy

Speaker: Mr O. Emilsson (Lund, SE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mr Oskar Love Emilsson

Lund University, Lund (Sweden)

0 follower

5 more presentations in this session

Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Speaker: Doctor M. Susanti (Jawa Timur, ID)

Impact of Beta-Blocker Prescription at Discharge on Long-term Clinical Outcomes in ST elevation Myocardial Infarction Patients with Reduced LVEF treated with Drug-eluting Stents

Speaker: Professor S. Park (Seoul, KR)

Impact of guidelines on Newer P2Y12 inhibitor use among ACS patients undergoing PCI

Speaker: Doctor M. Mohamed (London, GB)

Early initiation of PCSK9 inhibitors in acute STEMI: Interim results of safety and efficacy from the EARLY-STEMI trial

Speaker: Doctor M. Ali (Doha, QA)

Efficacy and safety of ticagrelor versus clopidogrel in acute myocardial infarction-associated cardiogenic shock: a propensity score-matched analysis

Speaker: Doctor M. Presume (Lisbon, PT)

Access the full session

Pharmacotherapy in acute coronary syndromes (1)

Speakers: Mr O. Emilsson, Doctor M. Susanti, Professor S. Park, Doctor M. Mohamed, Doctor M. Ali...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources